Guided Therapeutics (GTHP) Enterprise Value (QoQ) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Guided Therapeutics - - 458,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 27.59%
Sep 30, 2025 52.97%
Jun 30, 2025 -60.87%
Mar 31, 2025 70.36%
Dec 31, 2024 -100.00%
Sep 30, 2024 29.45%
Jun 30, 2024 38.20%
Mar 31, 2024 24.70%
Dec 31, 2023 19.15%
Sep 30, 2023 46.17%
Jun 30, 2023 26.08%
Mar 31, 2023 20.58%
Dec 31, 2022 14.24%
Sep 30, 2022 -504.71%
Jun 30, 2022 38.48%
Mar 31, 2022 -12.75%
Dec 31, 2021 -18.85%
Sep 30, 2021 41.32%
Jun 30, 2021 26.06%
Mar 31, 2021 -585.16%
Dec 31, 2020 68.67%
Sep 30, 2020 23.85%
Jun 30, 2020 -3,533.33%
Mar 31, 2020 97.66%
Sep 30, 2018 -70.73%
Jun 30, 2018 46.05%
Mar 31, 2018 -7,500.00%
Dec 31, 2017 98.65%
Sep 30, 2017 -825.00%
Jun 30, 2017 -700.00%
Mar 31, 2017 92.86%
Dec 31, 2016 -250.00%
Sep 30, 2016 81.82%
Jun 30, 2016 60.71%
Mar 31, 2016 -60.00%
Dec 31, 2015 79.65%
Sep 30, 2015 91.29%
Jun 30, 2015 -10,866.67%
Mar 31, 2015 88.89%
Dec 31, 2014 -285.71%
Sep 30, 2014 91.34%
Jun 30, 2014 -870.00%
Mar 31, 2014 91.84%
Dec 31, 2013 -53.25%
Sep 30, 2013 79.80%
Jun 30, 2013 -78.54%
Mar 31, 2013 -6.12%
Dec 31, 2012 58.28%
Sep 30, 2012 -87.50%
Jun 30, 2012 -48.44%
Mar 31, 2012 57.06%
Dec 31, 2011 -85.82%
Sep 30, 2011 51.86%
Jun 30, 2011 -1.56%
Mar 31, 2011 27.09%